Why Is SciSparc Stock Skyrocketing On Thursday?

Benzinga05-29

SciSparc Ltd. (NASDAQ:SPRC) stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%. The massive upside comes on the heels of a pre-market announcement detailing a key ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2639697490?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/28/Man-Hand-With-Stock-Market-Graph-With-Ro_0.jpeg","is_english":true,"pubTime":"2026-05-29 00:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639697490","market":"us","top_or_hot":-1,"title":"Why Is SciSparc Stock Skyrocketing On Thursday?","media":"Benzinga","content":"<div>\n<p>SciSparc Ltd. (NASDAQ:SPRC) stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%.\nThe massive upside comes on the heels of a pre-market announcement detailing a key ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is SciSparc Stock Skyrocketing On Thursday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is SciSparc Stock Skyrocketing On Thursday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-29 00:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SciSparc Ltd. (NASDAQ:SPRC) stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%.\nThe massive upside comes on the heels of a pre-market announcement detailing a key ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday","article_id":"2639697490","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/28/Man-Hand-With-Stock-Market-Graph-With-Ro_0.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2639697490","pubTimestamp":1779985680,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"SciSparc Ltd.  stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%.The massive upside comes on the heels of a pre-market announcement detailing a key regulatory milestone achieved by the Tel Aviv-based pharmaceutical player’s majority-owned subsidiary.SciSparc stock is showing exceptional strength. What’s driving SPRC stock higher?SciSparc announced that its subsidiary, NeuroThera Labs Inc., received conditional regulatory approval from the TSX Venture Exchange. The approval clears a path for NeuroThera to acquire an approximate 54% majority stake in CliniQuantum Ltd.Under the terms of the share purchase agreement  previously disclosed in March, NeuroThera will acquire 56,375 ordinary shares of CliniQuantum. In exchange, NeuroThera will issue 56.600 million common shares to the selling shareholders, representing an aggregate value of approximately $9.459 million.CliniQuantum, a private Israeli technology company, develops a platform that applies quan","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","SPRC":"SciSparc Ltd.","BK4139":"生物科技"},"translate_title":"为什么SciSparc股票周四暴涨？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SPRC":1},"content_text":"SciSparc Ltd. (NASDAQ:SPRC) stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%.\nThe massive upside comes on the heels of a pre-market announcement detailing a key regulatory milestone achieved by the Tel Aviv-based pharmaceutical player’s majority-owned subsidiary.\n       • SciSparc stock is showing exceptional strength. What’s driving SPRC stock higher?\nSciSparc announced that its subsidiary, NeuroThera Labs Inc., received conditional regulatory approval from the TSX Venture Exchange. The approval clears a path for NeuroThera to acquire an approximate 54% majority stake in CliniQuantum Ltd.\nUnder the terms of the share purchase agreement (SPA) previously disclosed in March, NeuroThera will acquire 56,375 ordinary shares of CliniQuantum. In exchange, NeuroThera will issue 56.600 million common shares to the selling shareholders, representing an aggregate value of approximately $9.459 million.\nCliniQuantum, a private Israeli technology company, develops a platform that applies quantum simulation and quantum Monte Carlo methods to clinical trial data analysis. The technology aims to improve the precision of clinical trial outcomes by identifying specific patient subpopulations that respond to investigational therapies.\nCliniQuantum’s material asset includes an exclusive, worldwide license agreement with Quantum X Labs Ltd., which holds a U.S. provisional patent application entitled “Generating Quantum Markov Chain Monte Carlo Sampling Points for Continuous Distribution Functions.”\nTo satisfy TSX feedback, NeuroThera and the selling shareholders amended the SPA on April 30. The amendment establishes a floor price of 5 cents per common share for future earn-out payments and implements lock-up arrangements.\nThe parties also extended the outside closing date to June 1 to finalize an Israeli tax ruling. Upon completion, all 56.600 million consideration shares will enter escrow under a Form 5D Escrow Agreement.\nSPRC Stock Price Activity: SciSparc shares were up 157.05% at $11.31 at the time of publication on Thursday, according to Benzinga Pro data.\nPhoto Courtesy: thirasap phaknara on Shutterstock.com\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639697490","isCrawlerRequest":true}